News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NanoSight Limited Announces a New Webinar on the EU Definition of Nanomaterials - the Impact of New Publications



11/6/2012 9:36:52 AM

Salisbury, UK, 6th November 2012: NanoSight, providers of unique nanoparticle characterization technology, will host a webinar update on Wednesday 14th November to discuss the impact of recent EU and JRC publications on the EU's nanomaterial definition.

There has been much discussion on the Joint Research Centre of the EU defining the measurement of nanomaterials in a review (1) entitled Requirements on measurements for the implementation of the European Commission definition of the Term "nanomaterial".

NanoSight invites interested parties to attend a webinar led by international nanotechnology legislation and control expert Dr Denis Koltsov, and Dr Matteo Dalla Valle of the REACH Centre, an organization that provides the highest quality advice on the many regulatory, technical and commercial aspects of REACh (2) and other chemical regulations. During the 30 minute interactive presentations, the speakers will:

Review the JRC methods document and discuss the key conclusions and the challenges presented.

Outline the EU's Second Regulatory Review and forthcoming legislation where it will have most impact, with particular emphasis on the REACh registration process.

Report on the USA perspective concerning regulation of nanomaterials. This will review topics from SENN2012 - International Congress on Safety of Engineered Nanoparticles and Nanotechnologies, held at the end of October in Helsinki.

As part of this interactive webinar series, attendees will be able to ask questions of the speakers. Register today at http://webinar.nanosight.com/.

References:

1: http://publications.jrc.ec.europa.eu/repository/bitstream/111111111/26399/2/irmm_nanomaterials%20%28online%29.pdf

2: REACH is the European Community Regulation on chemicals and their safe use (EC 1907/2006). It deals with the Registration, Evaluation, Authorization and Restriction of Chemical substances. The law came into force on 1 June 2007.

To find out about NanoSight, and to learn more about particle characterization using NanoSight's unique nanoparticle tracking analysis instrumentation, visit http://www.nanosight.com/ and register to receive the next issue of NanoTrail, the company's electronic newsletter.

About NanoSight:

NanoSight delivers the world's most versatile and proven multi-parameter nanoparticle analysis in a single instrument.

NanoSight's "Nanoparticle Tracking Analysis" (NTA) detects and visualizes populations of nanoparticles in liquids down to 10 nm, dependent on material, and measures the size of each particle from direct observations of diffusion. Additionally, NanoSight measures concentration and a fluorescence mode differentiates suitably-labelled particles within complex background suspensions. Zeta potential measurements are similarly particle-specific. It is this particle-by-particle methodology that takes NTA beyond traditional light scattering and other ensemble techniques in providing high-resolution particle size distributions and validates data with information-rich video files of the particles moving under Brownian motion.

This simultaneous multiparameter characterization matches the demands of complex biological systems, hence its wide application in development of drug delivery systems, of viral vaccines, and in nanotoxicology. This real-time data gives insight into the kinetics of protein aggregation and other time-dependent phenomena in a qualitative and quantitative manner. NanoSight has a growing role in biodiagnostics, being proven in detection and speciation of nanovesicles (exosomes) and microvesicles.

NanoSight has installed more than 500 systems worldwide with users including BASF, GlaxoSmithKline, Merck, Novartis, Pfizer, Proctor and Gamble, Roche and Unilever together with the most eminent universities and research institutes. NanoSight's technology is validated by 500+ third party papers citing NanoSight results. Furthermore, an ASTM (American Society for Testing and Materials) protocol ASTM E3428 was recently published introducing NTA as a method for testing nanoparticles helps to consolidate NanoSight's leadership position in nanoparticle characterization. For more information, visit http://www.nanosight.com/

For further information:

Please contact NanoSight direct or their marketing agency, Talking Science:

NanoSight Limited

Minton Park

London Road

Amesbury SP4 7RT UK

T +44(0)1980 676060

F +44(0)1980 624703

http://www.nanosight.com/

jeremy.warren@nanosight.com

Talking Science Limited

39 de Bohun Court

Saffron Walden

Essex CB10 2BA UK

T +44(0)1799 521881

M +44(0)7843 012997

http://www.talking-science.com/

jezz@talking-science.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES